ReproCELL|进口试剂采购网

ReproCELL

Reprocell REPROCELL由卓越的日本大学研究人员于2003年成立,迅速成为日本优越的干细胞研究公司。REPROCELL是**家为研究应用提供iPSC衍生的人心肌细胞,肝细胞和神经细胞的公司。作为市场领导者,该公司拥有细胞,培养基和试剂组合。

No.

品牌

货号

名称

规格

1

reprocell

01-0013-50

CryoStem Freezing Medium

50ml

2

reprocell

RCHETP002

Dissociation Solution for Human ES/iPS Cells

30ml

3

reprocell

RCHEFM001

Freezing Medium for Human ES/iPS Cells

25ml

4

reprocell

01-0014-500

hES Cell Cloning & Recovery Supplement

5*100ul

5

reprocell

NP892-061

iMatrix-221 Cardiac & Myoblast Cell Culture Substrate

2*175ug

6

reprocell

NP892-041

iMatrix-411 Endothelial Cell Substrate

2*175ug

7

reprocell

NP892-021

iMatrix-511 SILK Stem Cell Culture Substrate

6*175ug

8

reprocell

NP892-011

iMatrix-511 Stem Cell Culture Substrate

2*175ug

9

reprocell

RCHEOT004

Laminin-5 (Laminin-332)

1ug

10

reprocell

00-0055

Alkaline Phosphatase Staining Kit II

50 assays

11

reprocell

09-0034

Goat anti-Rabbit IgG Antibody (DyLight 488)

200ul

12

reprocell

09-0021

Klf4 Antibody (Purified), Mouse anti-Mouse/Human

100ul

13

reprocell

09-0024

Sox2 Antibody (Affinity Purified), Rabbit anti-Mouse/Human

100ul

14

reprocell

09-0020

Nanog Antibody (Affinity Purified), Rabbit anti-Mouse/Human

100ul

15

reprocell

09-0023

Oct4 Antibody (Affinity Purified), Rabbit anti-Mouse/Human

100ul

About REPROCELL Overview Established in 2003 by preeminent Japanese university researchers, REPROCELL quickly became the leading stem cell research company in Japan. Soon thereafter, REPROCELL products were employed by Professor Shinya Yamanaka (Nobel Laureate, 2012) during his pioneering research on induced pluripotent stem cell (iPSC) technologies at Kyoto University. REPROCELL was the first company to offer iPSC-derived human cardiomyocytes, hepatocytes and neuronal cells for research applications. As a market leader, with a portfolio of cells, culture media and reagents, the company was listed on the Japan JASDAQ / Growth stock market in 2013. In recent years, many commercial opportunities and applications were developed directly upstream and downstream of the iPSC workflow. Therefore, the company aggressively expanded its busines through a series of acquistions to become the REPROCELL Group Companies. Each company it acquired possessed intellectual property and knowledge that helps to amplify the value of the organization by complementing the capabilities of the others. Together, a workflow has emerged that spans from human tissue acquisition (BioServe®, Biopta®), to iPSC reprogramming (Stemgent®), cell differentiation (REPROCELL), in vitro tissue modelling with 3D technology (Reinnervate®), and assay development for applications in drug discovery (Biopta®). More recently, these companies have been integrated and consolidated to regional offices, and the names converted to product and service brands. In the stem cell and drug discovery “market- space”, no other company has this broad combination of expertise that can be applied to nearly the entire span of the drug discovery pipeline, and even to new areas of regenerative medicine. For a concise summary of REPROCELL's overall capabilities, you can reference our Corporate Capabilities Guide (PDF).

REPROCELL USA Inc REPROCELL USA Inc. Registered office REPROCELL USA Inc., 9000 Virginia Manor Road, Suite 207, Beltsville, 20705, USA, Registered in United States VAT no. 521660687

新闻动态
行业前沿
技术文章
*新产品
分享到:

沪公网安备 31011202007338号